Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
4.91M
-
Shares change
-
+229K
-
Total reported value, excl. options
-
$392M
-
Value change
-
+$18.2M
-
Put/Call ratio
-
0.2
-
Number of buys
-
45
-
Number of sells
-
-34
-
Price
-
$79.86
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q3 2023
114 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q3 2023.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.91M shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (1.65M shares), BANK OF AMERICA CORP /DE/ (669K shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (344K shares), Avalon Trust Co (288K shares), BNP PARIBAS ARBITRAGE, SNC (252K shares), JPMORGAN CHASE & CO (203K shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (153K shares), Prime Capital Investment Advisors, LLC (148K shares), Miller Investment Management, LP (144K shares), and Phoenix Holdings Ltd. (115K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.